Citation: T. Kikumori et al., Promiscuity of pre-mRNA spliceosome-mediated trans splicing: A problem forgene therapy?, HUM GENE TH, 12(11), 2001, pp. 1429-1441
Authors:
Koch, CA
Huang, SC
Moley, JF
Azumi, N
Chrousos, GP
Gagel, RF
Zhuang, ZP
Pacak, K
Vortmeyer, AO
Citation: Ca. Koch et al., Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma, ONCOGENE, 20(53), 2001, pp. 7809-7811
Authors:
Wohllk, N
Becker, P
Youlton, R
Cote, GJ
Gagel, RF
Citation: N. Wohllk et al., Germline mutations of the ret proto-oncogen in Chilean patients with hereditary and sporadic medullary thyroid carcinoma, REV MED CHI, 129(7), 2001, pp. 713-718
Authors:
McCutcheon, IE
Pieper, DR
Fuller, GN
Benjamin, RS
Friend, KE
Gagel, RF
Citation: Ie. Mccutcheon et al., Pituitary carcinoma containing gonadotropins: Treatment by radical excision and cytotoxic chemotherapy: Case report, NEUROSURGER, 46(5), 2000, pp. 1233-1239
Authors:
Yeung, SJ
McCutcheon, IE
Schultz, P
Gagel, RF
Citation: Sj. Yeung et al., Use of long-term intravenous phosphate infusion in the palliative treatment of tumor-induced osteomalacia, J CLIN END, 85(2), 2000, pp. 549-555
Authors:
Huang, SC
Koch, CA
Vortmeyer, AO
Pack, SD
Lichtenauer, UD
Mannan, P
Lubensky, IA
Chrousos, GP
Gagel, RF
Pacak, K
Zhuang, ZP
Citation: Sc. Huang et al., Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas, CANCER RES, 60(22), 2000, pp. 6223-6226
Authors:
Dackiw, APB
Sussman, JJ
Fritsche, HA
Delpassand, ES
Stanford, P
Hoff, A
Gagel, RF
Evans, DB
Lee, JE
Citation: Apb. Dackiw et al., Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism, ARCH SURG, 135(5), 2000, pp. 550-555
Citation: Rf. Gagel et G. Cote, The ret signaling system and its role in hereditary medullary thyroid carcinoma, GENETICS OF OSTEOPOROSIS AND METABOLIC BONE DISEASE, 2000, pp. 295-308
Authors:
Dang, GT
Cote, GJ
Schultz, PN
Khorana, S
Decker, RA
Gagel, RF
Citation: Gt. Dang et al., A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy, MOL CELL PR, 13(1), 1999, pp. 77-79
Citation: H. Lou et al., Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3 '-terminal exon, MOL CELL B, 19(1), 1999, pp. 78-85
Citation: R. Parthasarathy et al., Hammerhead ribozyme-mediated inactivation of mutant RET in medullary thyroid carcinoma, CANCER RES, 59(16), 1999, pp. 3911-3914
Authors:
Lee, JE
Evans, DB
Hickey, RC
Sherman, SI
Gagel, RF
Abbruzzese, MC
Abbruzzese, JL
Citation: Je. Lee et al., Unknown primary cancer presenting as an adrenal mass: Frequency and implications for diagnostic evaluation of adrenal incidentalomas, SURGERY, 124(6), 1998, pp. 1115-1122